Wellbiotec Co. Ltd. Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Wellbiotec Co. Ltd. capital reinvestment ratio. Wellbiotec Co. Ltd. (010600) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow (₩2.72 Billion) in capital expenditures (₩10.89 Million). Check Wellbiotec Co. Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.72 Billion
KRW

Capital Expenditures

₩10.89 Million
KRW

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of Wellbiotec Co. Ltd. (2005–2022)

Capital reinvestment ratio of Wellbiotec Co. Ltd. from 2005 to 2022. This chart tracks Wellbiotec Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. Also explore Wellbiotec Co. Ltd. equity growth rate to track the company's year-over-year net asset growth rate.

Wellbiotec Co. Ltd. Capital Reinvestment Ratio by Year (2005–2022)

Wellbiotec Co. Ltd. capital reinvestment ratio by year from 2005 to 2022. For the full cash flow conversion analysis, see Wellbiotec Co. Ltd. operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 0.19x ₩2.62 Billion ₩508.76 Million ▼ -75.6%
2021 0.79x ₩712.97 Million ₩565.92 Million ▲ +259.3%
2015 0.22x ₩4.28 Billion ₩944.92 Million ▼ -20.8%
2013 0.28x ₩1.01 Billion ₩281.62 Million ▲ +3.1%
2012 0.27x ₩3.06 Billion ₩826.93 Million ▲ +80.2%
2010 0.15x ₩2.90 Billion ₩435.67 Million ▼ -94.0%
2008 2.51x ₩3.11 Billion ₩7.82 Billion ▲ +212.3%
2006 0.81x ₩4.49 Billion ₩3.62 Billion ▼ -79.2%
2005 3.87x ₩1.48 Billion ₩5.72 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow